Leukocyte Surface Antigen CD47 Market Technology & Product Trends

aggiunto articolo blog Health

2026-07-01 09:36:57 -

Technology innovation defines the Leukocyte Surface Antigen CD47 Market, with monoclonal antibody therapies leading development. These antibodies block CD47-SIRPα interaction, triggering macrophage phagocytosis of cancer cells. Recent advances enhance efficacy while reducing on-target toxicity, a historical challenge in CD47 drug development. Small molecules offer oral bioavailability...

0 Commenti 0 Condivisioni 15 Visualizzazioni